Enlivex Therapeutics Ltd.
(ENLV)
undefined
undefined%
At close: undefined
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Revenue | - | - | - | 2.28M | - | - | - | - | - | - | - | - |
Cost of Revenue | 835.00K | 777.00K | 546.00K | 286.00K | 297.00K | 121.00K | 12.00K | 25.00K | 17.00K | - | - | - |
Gross Profit | -835.00K | -777.00K | -546.00K | 1.99M | -297.00K | -121.00K | -12.00K | -25.00K | -17.00K | - | - | - |
Operating Income | -29.39M | -25.80M | -19.29M | -9.79M | -8.62M | -5.30M | -5.96M | -15.87M | -15.48M | -7.08M | -1.15M | -226.00K |
Interest Income | 1.56M | 835.00K | 120.00K | 225.00K | 238.00K | 138.00K | 39.00K | 90.00K | 186.00K | 85.00K | - | - |
Pretax Income | -29.07M | -31.06M | -14.47M | -11.82M | -9.38M | -4.24M | -5.92M | -15.81M | -15.34M | -7.02M | -1.15M | -229.00K |
Net Income | -29.07M | -42.41M | -9.65M | -13.86M | -10.15M | -4.24M | -5.95M | -16.02M | -15.37M | -7.02M | -1.15M | -229.00K |
Selling & General & Admin | 6.14M | 6.70M | 6.24M | 3.60M | 2.75M | 937.00K | 3.44M | 6.99M | 7.78M | 2.64M | 416.00K | 86.00K |
Research & Development | 19.23M | 18.69M | 12.88M | 6.09M | 5.72M | 4.25M | 2.52M | 8.88M | 7.69M | 4.44M | 732.00K | 140.00K |
Other Expenses | 4.02M | 402.00K | 167.00K | 97.00K | 145.00K | - | - | - | -829.00K | - | - | - |
Operating Expenses | 29.39M | 25.80M | 19.29M | 9.79M | 8.62M | 5.30M | 5.96M | 15.87M | 15.48M | 7.08M | 1.15M | 226.00K |
Interest Expense | 14.00K | 5.26M | 328.00K | 6.00K | 7.00K | - | - | - | - | - | 2.00K | - |
Selling & Marketing Expenses | - | - | - | - | - | - | 479.00K | - | 829.00K | - | - | - |
Cost & Expenses | 29.39M | 25.80M | 19.29M | 9.79M | 8.62M | 5.30M | 5.96M | 15.87M | 15.48M | 7.08M | 1.15M | 226.00K |
Income Tax | - | 11.35M | -4.82M | 2.04M | 765.00K | 1.06M | 28.00K | 216.00K | 24.00K | - | 2.00K | - |
Shares Outstanding (Basic) | 18.57M | 18.39M | 17.86M | 13.17M | 8.65M | 3.51M | 414.20K | 397.65K | 355.76K | 306.49K | 271.85K | 271.85K |
Shares Outstanding (Diluted) | 18.57M | 18.39M | 17.86M | 13.17M | 8.65M | 3.51M | 428.24K | 397.65K | 355.76K | 306.49K | 271.85K | 271.85K |
EPS (Basic) | -1.56 | -2.31 | -0.54 | -1.05 | -1.17 | -1.21 | -14.35 | -40.29 | -43.19 | -22.91 | -4.21 | -0.84 |
EPS (Diluted) | -1.56 | -2.31 | -0.54 | -1.05 | -1.17 | -1.21 | -13.88 | -40.29 | -43.19 | -22.91 | -4.21 | -0.84 |
EBITDA | -28.22M | -25.02M | -18.74M | -9.50M | -9.08M | -5.18M | -5.91M | -15.78M | -15.31M | -7.08M | -1.14M | -226.00K |
Depreciation & Amortization | 835.00K | 777.00K | 546.00K | 286.00K | 297.00K | 121.00K | 12.00K | 25.00K | 17.00K | 5.00K | 5.00K | - |